June 3, 2025

Evolent Health, Inc. (EVH) Stock Analysis: Is There a 99% Upside Potential on the Horizon?

Evolent Health, Inc. (NYSE: EVH) is making waves within the healthcare sector, specifically in the health information services industry. With a market capitalization of $888.72 million,..

The Pennant Group, Inc. (PNTG) Stock Analysis: Exploring 14.46% Potential Upside in the Healthcare Sector

The Pennant Group, Inc. (NASDAQ: PNTG) is making waves in the healthcare sector, particularly within the medical care facilities industry. With a focus on providing essential..

Healthcare Services Group, Inc. (HCSG) Stock Analysis: A Stable Player in the Healthcare Sector with a 7.22% Upside

Healthcare Services Group, Inc. (NASDAQ: HCSG) stands as a notable entity in the healthcare sector, providing a range of essential services across the United States. Despite..

Pacira BioSciences, Inc. (PCRX) Stock Analysis: Healthcare Innovator with 15.85% Upside Potential

Pacira BioSciences, Inc. (NASDAQ: PCRX), a key player in the healthcare sector specializing in non-opioid pain management, presents an intriguing opportunity for investors seeking exposure to..

NeoGenomics, Inc. (NEO) Stock Analysis: A 55% Potential Upside Sparks Investor Interest

Investors with an eye on the healthcare sector may find NeoGenomics, Inc. (NASDAQ: NEO) an intriguing candidate, particularly given the company’s substantial potential upside of over..

Opko Health, Inc. (OPK): Investor Outlook Highlights Potential 189% Upside

Investors with an eye on the healthcare sector may find Opko Health, Inc. (NASDAQ: OPK) an intriguing prospect. With a market capitalization of $1.09 billion, this..

10x Genomics, Inc. (TXG) Stock Analysis: Evaluating the 31.90% Potential Upside

As investors navigate the challenging landscape of healthcare stocks, 10x Genomics, Inc. (NASDAQ: TXG) presents a compelling case for consideration, especially with the potential upside of..

Indivior PLC (INDV) Stock Analysis: Evaluating the 17.71% Potential Upside Amidst Market Challenges

Investors with a keen eye on the healthcare sector may want to take a closer look at Indivior PLC (INDV), a prominent player in the specialty..

Dynavax Technologies Corporation (DVAX): Investor Outlook with a 136% Potential Upside

Dynavax Technologies Corporation (NASDAQ: DVAX), a biopharmaceutical company specializing in vaccines, presents an intriguing investment opportunity for those looking to navigate the healthcare sector. With a..

Kestra Medical Technologies (KMTS) Stock Analysis: A 32.98% Potential Upside in the Healthcare Sector

In the ever-evolving landscape of healthcare, Kestra Medical Technologies, Ltd. (KMTS) has emerged as a noteworthy player with a unique focus on wearable medical devices. As..

Amphastar Pharmaceuticals (AMPH) Investor Outlook: Assessing a 27.66% Upside Potential in a Volatile Market

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH) presents a compelling case for investors seeking opportunities in the healthcare sector, particularly within the specialty and generic drug manufacturing industry...

Pulse Biosciences, Inc (PLSE): Investor Outlook on a Healthcare Innovator with a $1.14 Billion Market Cap

Pulse Biosciences, Inc. (NASDAQ: PLSE), a notable player in the healthcare sector, has carved a niche for itself as a pioneer in the field of bioelectric..

Bausch Health Companies Inc. (BHC) Stock Analysis: Unveiling a Potential 58% Upside

Investors focusing on the healthcare sector might find Bausch Health Companies Inc. (NYSE: BHC) a compelling opportunity, particularly due to the potential 58.11% upside based on..

Biohaven Ltd. (BHVN) Stock Analysis: High Analyst Confidence with a 257% Upside Potential

Individual investors seeking opportunities in the biotechnology sector may find Biohaven Ltd. (BHVN) an intriguing prospect. With its focus on cutting-edge therapies in immunology, neuroscience, and..

Liquidia Corporation (LQDA) Stock Analysis: Exploring the 86.72% Potential Upside

Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical company at the forefront of addressing unmet patient needs, has caught the attention of investors with its impressive 86.72% potential..

PACS Group, Inc. (PACS) Stock Analysis: A Healthcare Play with a 261.88% Potential Upside

Investors seeking opportunities in the healthcare sector might find PACS Group, Inc. (PACS) an intriguing proposition. Operating within the medical care facilities industry, PACS is renowned..

Tarsus Pharmaceuticals, Inc. (TARS) Stock Analysis: Unveiling a 68.47% Potential Upside in the Biotech Sector

For investors keen on the biotechnology sector, Tarsus Pharmaceuticals, Inc. (TARS) emerges as a notable contender with an attractive growth prospect. As a commercial-stage biopharmaceutical company,..

MiMedx Group, Inc. (MDXG) Stock Analysis: Exploring an 87.79% Potential Upside in the Biotech Sector

MiMedx Group, Inc. (NASDAQ: MDXG), a prominent player in the biotechnology industry, stands out with a compelling 87.79% potential upside, according to analyst ratings. With a..

Innoviva, Inc. (INVA) Stock Analysis: Unveiling a 173% Potential Upside in the Biotech Sector

Innoviva, Inc. (NASDAQ: INVA), a prominent player in the biotechnology sector, is capturing investor attention with its substantial potential upside. With an average target price of..

Belite Bio, Inc (BLTE) Stock Analysis: A Biotech Innovator with 30.73% Upside Potential

Belite Bio, Inc (NASDAQ: BLTE) is catching the attention of investors with its promising advancements in the biotechnology sector, particularly in the field of retinal degenerative..

Search

Funds

June 3, 2025

Search

Funds

June 3, 2025

FTSE 100

Funds